Select the type of procedure
21055545
1
Enquiry period
with
22.04.2022 11:16
to 28.04.2022 10:00
to 28.04.2022 10:00
2
Bidding period
with
28.04.2022 10:00
to 13.05.2022 10:00
to 13.05.2022 10:00
3
Auction
16.05.2022 11:00
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
147 689,12 MDL
Period of clarifications:
22 Apr 2022, 11:16 - 28 Apr 2022, 10:00
Submission of proposals:
28 Apr 2022, 10:00 - 13 May 2022, 10:00
Supplier technical support:
(+373) 79999801
Subscribe impossible
during the period Evaluation
“Achiziționarea medicamentelor necesare tratamentului malariei, toxoplasmozei, holerei, serurilor și imunoglobulinelor curative în scopul realizării Programului Special “Combaterea maladiilor rare” pentru anul 2022, repetat 2”
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
22 Apr 2022, 10:40
Date modified
22 Apr 2022, 11:16
Achizitii.md ID
21055545
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 1 - Artemetherum + Lumefantrinum 20 mg+120 mg
Budget: 2576.0 MDL
Purchase has not taken place
Lot nr. 7 - Natrii chloridum + Kalii chloridum + Natrii hydrocarbonas (analog Trisol) 5 mg/1 mg/4 mg/ml 400 ml
Budget: 11638.0 MDL
Purchase has not taken place
Lot nr. 9 - Natrii chloridum+Kalii chloridum+Natrii acetas (analog Acesol) 5 mg+1mg+2 mg/ml 400 ml
Budget: 4655.2 MDL
Active
Lot nr. 12 - Serum anticarbunicum (Anthrax antitoxin) 10 ml
Budget: 10304.0 MDL
Purchase has not taken place
Documents of the procurement procedure
Propunerea financiara (Specificatii de pret)_Model
Technical Specifications
Propunerea financiară
22.04.22 11:16
Propunerea tehnica (Specificatii tehnice)_Model
Technical Specifications
Propunerea tehnică
22.04.22 11:16
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK